Catholic leaders in the U.S. have welcomed the news that one
of the world’s biggest vaccine producers has decided to switch to ethical polio
vaccine and discontinue a polio vaccine derived from an abortion fetal cell
line.
Sanofi-Pasteur, company among the three largest vaccine
manufacturers globally, will instead use an ethical animal cell line in the
production of its polio vaccine. The company has also committed itself to
developing a COVID-19 vaccine that does not use a cell line from an elective
abortion.
“We welcome these opportunities where we can illustrate the
Church’s eager embrace of scientific advancement when it upholds the dignity of
the human person and the precious gift of human life,” said Greg Schleppenbach,
associate director of the Secretariat of Pro-Life Activities for the U.S.
bishops’ conference.
In a Sept. 2 memo to diocesan pro-life directors and state
Catholic conference directors, Schleppenbach noted “that the FDA recently
approved Sanofi-Pasteur’s request to switch from using an aborted fetal cell
line (MRC-5) to using an ethical animal cell line to produce its polio
combination vaccines Pentacel and Quadracel.”
Sanofi-Pasteur has also announced that it will no longer
produce a stand-alone polio vaccine, Poliovax, which was created from the same
aborted fetal cell line. Instead, it will retain a different stand-alone
vaccine, IPOL, which was ethically developed.
“Furthermore, Sanofi-Pasteur’s ongoing effort to develop a
vaccine for COVID-19 also does not rely on cell lines linked to elective
abortion,” Schleppenbach said.
For years, ethical concerns have been raised about the
development of some vaccines with cells lines created from the cells of aborted
babies.
A 2005 document from the Pontifical Academy for
Life concluded that it is both morally permissible and morally responsible for
Catholics to use vaccines prepared in cell lines descended from aborted
fetuses, if no alternative is available.
However, the document said Catholics have an obligation to
use ethically-sourced vaccines when possible, and when alternatives do not
exist, they have an obligation to speak up and request the development of new
cell lines that are not derived from aborted fetuses.
“One important step we can take to ensure the
production of ethical vaccines is to recognize and thank drug companies, like
Sanofi-Pasteur, when they move away from unethical vaccine production,” said
Schleppenbach in his memo.
He asked local pro-life leaders to encourage Catholics to send
a note of thanks to Sanofi-Pasteur.
“We can hope that, with some encouragement, other vaccine
manufacturers may consider creating other morally acceptable vaccines,” he
said.
Schleppenbach also noted that the U.S. bishops’ conference
has “an active campaign urging the FDA to ensure that a COVID-19 vaccine
is produced free from complicity with abortion.”
“This move from Sanofi-Pasteur is an encouraging indicator
that for-profit companies creating vaccines are beginning to recognize there is
no need to use cell lines derived from aborted children,” he said.
Dr. Michael Parker, president of the Catholic Medical
Association and Dr. Joseph Meaney, president of the National Catholic Bioethics
Center, also applauded the development from Sanofi-Pasteur.
In a joint July 21 letter to Archbishop Joseph Naumann of
Kansas City, Kansas, who heads the U.S. bishops’ pro-life committee, Parker and
Meaney said the move means fewer ethical dilemmas for Catholic and pro-life
parents.
“Sanofi-Pasteur’s actions demonstrate that it is possible to
make safe and effective vaccines without resort to AFCLs [aborted fetal cell
lines], and even to remove AFCLs from vaccines currently in use,” they said.
“Sanofi-Pasteur’s approach to a vaccine for COVID-19 shows
its commitment to developing future vaccines without resorting to use of
AFCLs.”
“[T]oo often people have been told that there is not much
that can be done about the use of AFCLs in vaccines, particularly in pediatric
vaccines,” Parker and Meaney said.
They noted that the widespread use of these vaccines has
also been used to justify further unethical research.
“Sanofi-Pasteur’s actions show that moral and medical
progress is possible,” they said. “We should celebrate this and request—even
demand—more from the pharmaceutical industry.”
No comments:
Post a Comment